Improved glucose tolerance after effective lipid-lowering therapy with bezafibrate in a patient with lipoatrophic diabetes mellitus: A putative role for Randle's cycle in its pathogenesis?

Clinical Endocrinology

Volumn 46, Issue 3, 1997, Pages 365-368

  Panz, V R ^a   Wing, J R ^a   Raal, F J ^a   Kedda, M A ^a   Joffe, B I ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; C PEPTIDE; CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; CASE REPORT; DIET; FEMALE; HUMAN; LIPOATROPHIC DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031002711     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.970912.x     Document Type: Article

References (17)

1. Chiles, R. & Tzagournis, M. (1970) Excessive serum insulin response to oral glucose in obesity and mild diabetes. Diabetes, 19, 458-464.
2. Desbois-Mouthon, C., Magré, J., Amselem, S., Reynet, C., Blivet, M-J., Goossens, M., Capeau, J. & Besmond, C. (1995) Lipoatrophic diabetes: Genetic exclusion of the insulin receptor gene. Journal of Clinical Endocrinology and Metabolism, 80, 314-319.
3. Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes. (1988) Statement: nutritional recommendations for individuals with diabetes mellitus. Diabetes Nutrition and Metabolism, 1, 145-149.
4. Dörfler, H., Rauh, G. & Bassermann, R. (1993) Lipoatrophic diabetes. Clinical Investigation, 71, 264-269.
5. Golay, A., Swislocki, A.L.M., Chen, Y-D.I. & Reaven, G.M. (1987) Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin- dependent diabetic individuals. Metabolism, 36, 692-696.
6. Jones, I.R., Swai, A., Taylor, R., Miller, M., Laker, M.F. & Alberti, K.G.M.M. (1990) Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM. Diabetes Care, 13, 855-863.
7. Kadowaki, T., Kadowaki, M., Rechler, M.M. Serrano-Rios, M., Roth, J., Gorden, P. & Taylor, S.I. (1990) Five mutant alleles of the insulin receptor gene in patients with genetic forms of insulin resistance. Journal of Clinical Investigation, 86, 254-264.
8. Koller, E.A., Acilli, D. & Taylor, S.I. (1994) Mutations in the insulin receptor gene in insulin resistant patients. In Molecular Endocrinology: Basic Concepts and Clinical Observations (ed. B. D. Weintraub), pp. 283-296. Raven Press Ltd, New York.
9. Krook, A., Kumar, S., Laing, I., Boulton, A.J.M., Wass, J.A.H. & O'Rahilly, S. (1994) Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes, 43, 357-368.
10. Larsen, M.L. & Illingworth, D.R. (1993) Triglyceride-lowering agents: fibrates and nicotinic acid. Current Opinion in Lipidology. 4, 34-40.
11. O'Rahilly, S., Choi, W.H., Patel, P., Turner, R.C., Flier, J.S. & Moller, D.E. (1991) Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes, 40, 777-782.
12. Randle, P.J., Hales, C.N., Garland, P.B. & Newsholme, E.A. (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, i, 785-789.
13. Stacpoole, P.W., Alig, J., Kilgore, L.L., Alaya, C.M., Herbert, P.N., Zech, L.A. & Fisher, W.R. (1988) Lipodystrophic diabetes mellitus. Investigations of lipoprotein metabolism and the effects of ω-3-fatty acid administration in two patients. Metabolism, 37, 944-951.
14. Sykes, B.C. (1983) DNA in heritable disease. Lancet, ii, 787-788.
15. Taylor, S.I., Kadowaki, T., Acilli, D., Cama, A., Kadowaki, H., McKeon, C., Moncada, V., Marcus-Samuels, B., Bevins, C. Ojamaa, K., Frapier, C., Beitz, L., Perrotti, N., Rees-Jones, R., Margolis, R., Gorden, P. & Roth, J. (1990) Mutations in the insulin receptor gene in genetic forms of insulin resistance. Recent Progress in Hormone Research, 46, 185-217.
16. Unger, R.H. (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Diabetes, 44, 863-869.
17. Wang, L.M. & Korc, M. (1995) Searching for the Holy Grail: the cause of diabetes. Lancet, 346 (Suppl.), s4.